Work package 1.5
Hypothesis: Use of pro- or antibiotics improves feeding tolerance and health in preterm infants.
Probiotics, feeding and infections
Treatment from day 3 to discharge with probiotics has been standard clinical care for preterm infants in Copenhagen since March 2010. However, reports on the addition of probiotics to milk feeds for compromised newborn infants are not conclusive (23).
Methods
In retro- and prospective cohort studies, we compare clinical records (feeding, growth, antibiotic use, infection, other clinical complications), routine laboratory data, and fecal samples from day 3, 10 and 30 between untreated and treated infants born before 30 weeks of gestation. Comparison of 3+3 years allows us to detect a decrease in NEC incidence of 50%, i.e. what is expected based on recent meta-analyses (23).
Results
We document the association among probiotics treatment, NEC, feeding tolerance and clinical records of infections over the first 4 weeks after birth. Gut bacterial composition is analyzed by conventional culture-based and molecular techniques. The results will support decisions to implement new early feeding protocols, with and without addition of probiotics.
Synopsis
- Download synopsis for WP 1.5 - updated 2016
- Download synopsis for WP 1.5 - updated 2014
- Download synopsis for WP 1.5
Publications
Leaders for WP 1.5
- Gorm Greisen
- Karen Krogfelt
Work package 1
WP 1.1
Caesarean birth affects the gut microbiota and infection resistance in infants
WP 1.2
Infant infection rates are associated with birth method, breast-feeding and antibiotics
WP 1.3
Infant health is improved by adding probiotics or milk bioactives to infant formula
WP 1.4
Human banked milk is superior to formula for growth/immunity in preterm infants
WP 1.5
Use of pro- or antibiotics improves feeding tolerance and health in preterm infants
WP 1.6
Early enteral feeding, with or without probiotics, supports preterm infant health
WP 1.7
Social, cultural and ethical values limit new dietary treatments for infants